Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats

被引:33
|
作者
Terzian, Ana Luisa B. [1 ,2 ]
dos Reis, Daniel Gustavo [3 ]
Guimares, Francisco S. [3 ,4 ]
Correa, Fernando M. A. [3 ]
Resstel, Leonardo B. M. [3 ,4 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, BR-14049900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Contextual fear; TRPV1; receptors; Prefrontal cortex; Cardiovascular system; Rats; CARDIOVASCULAR-RESPONSES; REVERSIBLE INACTIVATION; ENDOCANNABINOID SYSTEM; SYNAPTIC-TRANSMISSION; EMOTIONAL RESPONSES; INFRALIMBIC CORTEX; PRELIMBIC CORTEX; ANXIETY; MODULATION; LESIONS;
D O I
10.1007/s00213-013-3211-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Contextual fear is evoked by re-exposing an animal to an environment that has been previously paired with an aversive or unpleasant stimulus. It can be assessed by freezing and cardiovascular changes such as increase in mean arterial pressure and heart rate. A marked increase in neuronal activity is associated with contextual fear conditioning, especially in limbic structures involved with defense reactions, such as the ventral portion of medial prefrontal cortex. Given the fact that transient receptor potential vanilloid type 1 (TRPV1) receptors could be involved in the expression of defensive behavior, the present work tested the hypothesis that TRPV1 manipulation in the ventromedial prefrontal cortex (vMPFC) modulates the expression of contextual conditioned fear. Male Wistar rats received bilateral microinjections into the vMPFC of the TRPV1 receptor antagonists capsazepine (1, 10, and 60 nmol/200 nL) or 6-iodonordihydrocapsaicin (3 nmol/200 nL), and the TRPV1 agonist capsaicin (1 nmol/200 nL) preceded by vehicle or 6-iodonordihydrocapsaicin before re-exposure to the experimental chamber for 10 min, 48 h after conditioning in two different protocols distinct by their aversiveness. Both antagonists reduced the freezing and cardiovascular responses in the high aversive protocol. Capsaicin caused an increase in fear-associated responses that could be blocked by 6-iodonordihydrocapsaicin. Our results indicate that TRPV1 receptors located in the vMPFC have a tonic involvement in the modulation of the expression of contextual fear conditioning.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [1] Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats
    Ana Luisa B. Terzian
    Daniel Gustavo dos Reis
    Francisco S. Guimarães
    Fernando M. A. Corrêa
    Leonardo B. M. Resstel
    Psychopharmacology, 2014, 231 : 149 - 157
  • [2] Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats
    Daniele C. Aguiar
    Ana Luisa B. Terzian
    Francisco S. Guimarães
    Fabrício A. Moreira
    Psychopharmacology, 2009, 205 : 217 - 225
  • [3] Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats
    Aguiar, Daniele C.
    Terzian, Ana Luisa B.
    Guimares, Francisco S.
    Moreira, Fabricio A.
    PSYCHOPHARMACOLOGY, 2009, 205 (02) : 217 - 225
  • [4] Vascular Expression of Transient Receptor Potential Vanilloid 1 (TRPV1)
    Sand, Claire A.
    Grant, Andrew D.
    Nandi, Manasi
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2015, 63 (06) : 449 - 453
  • [5] Expression of transient receptor potential vanilloid 1, TRPV1, by synovial macrophages
    Seegers, HC
    Avery, PS
    Williams, DF
    Suri, S
    Walsh, DA
    RHEUMATOLOGY, 2005, 44 : I37 - I37
  • [6] GANGLIOSIDE MODULATION OF CAPSAICIN/TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 RECEPTOR (TRPV1) FUNCTION AND EXPRESSION
    Jancso, G.
    Oszlacs, O.
    Dobos, I.
    Dux, M.
    Santha, P.
    NEUROPEPTIDES, 2009, 43 (05) : 427 - 427
  • [7] Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart
    Thilo, Florian
    Liu, Ying
    Schulz, Nico
    Gergs, Ulrich
    Neumann, Joachim
    Loddenkemper, Christoph
    Gollasch, Maik
    Tepel, Martin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (01) : 98 - 103
  • [8] IS TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 (TRPV1) A NEW TARGET FOR CARDIOPROTECTION?
    AL-Mawla, R.
    Paita, L.
    Bidault-Ducreux, S.
    Chouabe, C.
    Durand, A.
    Augeul, L.
    Dupre-Aucouturier, S.
    Bonvallet, R.
    Ovize, M.
    Van Coppenolle, F.
    JOURNAL OF HYPERTENSION, 2016, 34 : E212 - E213
  • [9] Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin
    Raisinghani, M
    Pabbidi, RM
    Premkumar, LS
    JOURNAL OF PHYSIOLOGY-LONDON, 2005, 567 (03): : 771 - 786
  • [10] Activation of transient receptor potential vanilloid 1 (TRPV1) by methylsalicylate
    Ohta, Toshio
    Ito, Shigeo
    Imagawa, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 194P - 194P